TrialBritish journal of cancer2018

KRAS mutations in cell-free DNA from preoperative and postoperative sera as a pancreatic cancer marker: a retrospective study.

Yutaka Nakano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.